We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
(+11%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$141M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$96.6M |
| 4 |
Amazon
AMZN
|
+$63.7M |
| 5 |
Prologis
PLD
|
+$47.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$56.3M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$36M |
| 3 |
Y
Alleghany Corp
Y
|
+$33M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$26.6M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$20.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.05% |
| 2 | Healthcare | 14.94% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 10% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Nautilus Biotechnolgy
NAUT
$115M
| $125K | ﹤0.01% |
69,386
+392
| +0.6% | +$757 |
|
|
THRX
2877
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $125K | ﹤0.01% |
25,002
+154
| +0.6% | +$902 |
|
2878
Bioventus
BVS
$1.19B
| $124K | ﹤0.01% |
47,499
+156
| +0.3% | +$681 |
|
2879
Invivyd
IVVD
$218M
| $122K | ﹤0.01% |
81,271
+374
| +0.5% | +$1.04K |
|
2880
Velocity Financial
VEL
$729M
| $122K | ﹤0.01% |
12,691
+248
| +2% | +$2.48K |
|
2881
NLI Holdings
NL
$317M
| $120K | ﹤0.01% |
17,642
+206
| +1% | +$1.54K |
|
|
ATCX
2882
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $120K | ﹤0.01% |
23,219
+27
| +0.1% | +$168 |
|
|
CLPR
2883
Clipper Realty
CLPR
$46.2M
| $119K | ﹤0.01% |
18,592
-193
| -1% | -$1.35K |
|
2884
Vitamin Cottage Natural Grocers
NGVC
$654M
| $119K | ﹤0.01% |
12,977
-421
| -3% | -$4.43K |
|
2885
Priority Technology Holdings
PRTH
$444M
| $116K | ﹤0.01% |
22,016
+1,258
| +6% | +$6.38K |
|
|
SCWX
2886
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $116K | ﹤0.01% |
18,094
+295
| +2% | +$2.08K |
|
|
SKYT
2887
DELISTED
SkyWater Technology
SKYT
| $113K | ﹤0.01% |
15,866
-33
| -0.2% | -$279 |
|
2888
ThredUp
TDUP
$422M
| $113K | ﹤0.01% |
86,416
+1,640
| +2% | +$2.25K |
|
|
VBIV
2889
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $113K | ﹤0.01% |
9,639
+306
| +3% | +$5.4K |
|
2890
Ondas Inc
ONDS
$5.19B
| $112K | ﹤0.01% |
70,414
+30,387
| +76% | +$89.3K |
|
|
CURO
2891
DELISTED
CURO Group Holdings Corp.
CURO
| $112K | ﹤0.01% |
31,452
+2,012
| +7% | +$7.67K |
|
|
PLM
2892
DELISTED
PolyMet Mining Corp.
PLM
| $112K | ﹤0.01% |
42,247
+661
| +2% | +$1.9K |
|
2893
Applied Digital
APLD
$8.41B
| $111K | ﹤0.01% |
60,260
+47,367
| +367% | +$93.4K |
|
|
CTV
2894
DELISTED
Innovid Corp.
CTV
| $111K | ﹤0.01% |
65,204
+9,317
| +17% | +$25.2K |
|
2895
Humacyte
HUMA
$194M
| $108K | ﹤0.01% |
51,306
+28,522
| +125% | +$86.6K |
|
2896
Inseego
INSG
$90.5M
| $107K | ﹤0.01% |
12,728
-646
| -5% | -$9.7K |
|
2897
Bakkt Inc
BKKT
$337M
| $106K | ﹤0.01% |
3,552
| – | – |
|
2898
Urban One Class D
UONEK
$23.8M
| $106K | ﹤0.01% |
2,829
+759
| +37% | +$33.7K |
|
2899
Weave Communications
WEAV
$423M
| $104K | ﹤0.01% |
22,759
+490
| +2% | +$2.41K |
|
|
LTCH
2900
DELISTED
Latch, Inc. Common Stock
LTCH
| $104K | ﹤0.01% |
147,151
+8,932
| +6% | +$8.18K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.
- RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
- RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
- RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
- RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
- RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
- RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.